In contrast to FLT3ITD, bromodomain and extra-terminal (BET) proteins, such as BRD4, which read chromatin and regulate transcription, are non-oncogene addiction targets in MLL-AF9-positive AML [47]. The gene discussed is BRD4; the disease is acute myeloid leukemia.